These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6757139)

  • 1. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.
    Bos RP; Leenaars AO; Theuws JL; Henderson PT
    Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity in urine from nurses handling cytostatic agents.
    Benhamou S; Callais F; Sancho-Garnier H; Min S; Courtois YA; Festy B
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1489-93. PubMed ID: 3595674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handling of cytostatic drugs and urine mutagenesis.
    Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G
    Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.
    DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G
    Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
    Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
    Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
    Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
    Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity studies and D-glucaric acid determination in urine of workers exposed to mineral oils.
    Pasquini R; Monarca S; Sforzolini GS; Savino A; Angeli G
    Int Arch Occup Environ Health; 1985; 56(4):275-84. PubMed ID: 3905625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary mutagenicity tests in lead-exposed workers.
    Apostoli P; Leone R; Porru S; Fracasso ME; Alessio L
    Mutat Res; 1989 Mar; 222(3):245-51. PubMed ID: 2646535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenic activity of overnight urine from healthy non-smoking subjects.
    Pavanello S; Lupi S; Pulliero A; Gregorio P; Saia BO; Clonfero E
    Environ Mol Mutagen; 2007 Mar; 48(2):143-50. PubMed ID: 17295305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of dibromodulcitol (DBD), an alkylating anticancer drug) and its mono- and bifunctional conversion products studied by the Salmonella/microsome assay.
    Tóth K; Sugár J; Somfai-Relle S; Hedegüs L
    Carcinogenesis; 1982; 3(3):333-6. PubMed ID: 7044598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.
    Stucker I; Hirsch A; Doloy T; Bastie-Sigeac I; Hemon D
    Int Arch Occup Environ Health; 1986; 57(3):195-205. PubMed ID: 3957439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity in urine of workers in rubber industry.
    Falck K; Sorsa M; Vainio H; Kilpikari I
    Mutat Res; 1980 Sep; 79(1):45-52. PubMed ID: 7001220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.
    Barale R; Sozzi G; Toniolo P; Borghi O; Reali D; Loprieno N; Della Porta G
    Mutat Res; 1985; 157(2-3):235-40. PubMed ID: 4022044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary excretion of mutagens and cisplatin among the nursing staff at a medical oncology department exposed to cytostatic drugs].
    Clonfero E; Granella M; Gori GP; Venier P; Levis AG; Morandi P; Bartolucci GB; Saia B
    Med Lav; 1989; 80(5):412-9. PubMed ID: 2622413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of urine from individuals exposed to LPG combustion products.
    Yin XJ; Liu JZ; Kong XH; Chu JH; Wang H; Xiao ZX
    Biomed Environ Sci; 1998 Sep; 11(3):251-7. PubMed ID: 9861484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity in urine of nurses handling cytostatic drugs.
    Falck K; Gröhn P; Sorsa M; Vainio H; Heinonen E; Holsti LR
    Lancet; 1979 Jun; 1(8128):1250-1. PubMed ID: 87722
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Salmonella typhimurium TA 98, YG 1024 and YG 1021 and deconjugating enzymes for evaluating the mutagenicity from smokers' urine.
    Kuenemann-Migeot C; Callais F; Momas I; Festy B
    Mutat Res; 1997 May; 390(3):283-91. PubMed ID: 9186578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for mutagens in an aluminium plant. The results of Salmonella typhimurium tests on urine from exposed workers.
    Krøkje A; Tiltnes A; Mylius E; Gullvåg B
    Mutat Res; 1988 Feb; 204(2):163-72. PubMed ID: 3278207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
    Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests.
    Labuhn K; Valanis B; Schoeny R; Loveday K; Vollmer WM
    Cancer Nurs; 1998 Apr; 21(2):79-89. PubMed ID: 9556934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.